Acute wound healing: An overview

Clinics in Plastic Surgery

Volumn 30, Issue 1, 2003, Pages 1-12

  Monaco, JoAn L ^a   Lawrence, W Thomas ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR; CHEMOTACTIC FACTOR; COLLAGEN; CYTOKINE; FIBRIN; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANTIGEN ANTIBODY COMPLEX; BLOOD CLOTTING; CELL MIGRATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; EPITHELIZATION; FIBRIN FORMATION; FIBROBLAST; HEMOSTASIS; INFLAMMATION; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; NEUTROPHIL CHEMOTAXIS; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; PROTEOGLYCAN SYNTHESIS; REVIEW; T LYMPHOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS; TISSUE REGENERATION; VASOCONSTRICTION; WOUND CONTRACTION; WOUND HEALING;

ANIMALS; BLOOD COAGULATION; CELL COMMUNICATION; CICATRIX; CYTOKINES; EPITHELIUM; HUMANS; INFLAMMATION; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET AGGREGATION; PROTEIN BIOSYNTHESIS; WOUND HEALING;

EID: 0037218023     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-1298(02)00070-6     Document Type: Review

References (88)

1. Cohen IK, Diegelman RF, Dome RY, et al. Wound care and wound healing. In: Schwartz SI, Shires GT, Spencer FC, et al, editors. Principles of surgery, seventh edition. New York: McGraw-Hill; 1999. p. 263-95.
2. Lawrence WT. Physiology of the acute wound. Clin Plas Surg 1998;25(3):321-40.
3. Cines DB, Pollack ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-61.
4. White JD, Gerrard JM. Ultrastructural features of abnormal platelets: a review. Am J Pathol 1976;83:589-632.
5. Hynes RO. Fibronectins. Sci Am 1986;254:42-61.
6. Deuel TF, Senior RM, Huang JS, et al. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest 1982;69:1046-9.
7. Dahlback B. Blood coagulation. Lancet 2000;355:1627-32.
8. Stiembery J, Redin WR, Warner WS, et al. The role of thrombin and thrombin receptor activating peptide (TRAP-508) in initiation of tissue repair. Thromb Haemost 1993;70:158-62.
9. Grinnell F. Fibronectin and wound healing. J Cell Biochem 1984;26:107-16.
10. Blatti SP, Foster DN, Ranganathan G, et al. Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc Natl Acad Sci USA 1988;85:1119-23.
11. Fukai F, Suzuki H, Suzuki K, et al. Rat plasma fibronectin contains two distinct chemotactic domains for fibroblastic cells. J Biol Chem 1991;266:8807-13.
12. Clark RA, Lanigan JM, DellaPelle P, et al. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound re-epithelialization. J Invest Dermatol 1982;79:264-9.
13. Wysocki AB, Grinell F. Fibronectin profiles in normal and chronic wound fluid. Lab Invest 1990;63:825-31.
14. Kloth LC, McCulloch JM, Feedar JA. Wound healing. In: Kloth LC, McCulloch JM, Feedar JA, editors. Wound healing: alternatives in management. Philadelphia: FA Davis Company; 1990. p. 3-13.
15. Majno G, Shea SM, Leventhal M. Endothelial contraction induced by histamine type mediators: an electron microscopic study. J Cell Biol 1969;42:647-72.
16. Cohen IK, Diegelman RF, Dome RY, et al. Wound healing. In: Greenfield LJ, Mulholland MW, Oldham KT, et al, editors. Surgery: scientific principles and practice. third edition. Philadelphia: Lippincott-Raven; 1993. p. 86.
17. Carter SB. Cell movement and cell spreading: a passive or an active process? Nature 1970;255:858-9.
18. Postlethwaite AE, Keski-Oja J, Ballan G, et al. Induction of fibroblast chemotaxis by fibronectin. J Exp Med 1981;153:494-9.
19. Glat PM, Longaker MT. Wound healing. In: Aston SJ, Besley RW, Thom CH, editors. Grabb and Smith's plastic surgery, fifth edition. Philadelphia: Lippincott-Raven; 1997. p. 3.
20. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987;84:5788-92.
21. Hynes RO. Integrins: a family of cell surface receptors. Cell 1987;48:549-54.
22. th edition. New York: McGraw-Hill; 1994. p. 1552.
23. Ono I. Roles of cytokines in wound healing processes. Nippon Geka Gakki Zasshi 1999; 100:522-8.
24. Newman SL, Henson JE, Henson PM. Phagocytosis of senescent neutrophils by human monocyte derived macrophages and rabbit inflammatory macrophages. J Exp Med 1982;156:430-42.
25. Ezekowitz RA, Williams DJ, Koziel H, et al. Uptake of Pneumocystis carnii mediated by the macrophage mannose receptor. Nature 1991;351:155-8.
26. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Matchison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 1990;249:1431-3.
27. Werb Z, Banda MJ, Jones PA. Degradation of connective tissue matrices by macrophages: proteolysis of elastin, glycoproteins and collagen by proteinases isolated from macrophages. J Exp Med 1980;152:1340-52.
28. Malawista SE, Montgomery RR, van Blaricom G. Evidence for reactive nitrogen intermediates in killing of staphylococci by human neutrophil cytoplasts. A new microbicidal pathway for polymorphonuclear leukocytes. J Clin Invest 1992;90:631-6.
29. Madden JW, Peacock Jr EE. Studies on the biology of collagen during wound healing: rate of collagen synthesis and deposition in cutaneous wounds of the rat. Surgery 1968;64:288-94.
30. McCartney-Francis N, Mizel D, Wong H, et al. Transforming growth factor-beta (TGF-β) as an immunoregulatory molecule [abstract]. FASEB J 1988;2:A875.
31. Schaffer MR, Tandry U, Gross SS, et al. Nitric oxide regulates wound healing. J Surg Res 1996;63:237-40.
32. Peterson JM, Barbul A, Breslin RJ, et al. Significance of T-lymphocytes in wound healing. Surgery 1987; 102:300-5.
33. Martin CW, Muir IF. The role of lymphocytes in wound healing. Br J Plast Surg 1990;43:655-62.
34. Nielson EG, Phillips SM, Jimeney S. Lymphokine modulation of fibroblast proliferation. J Immunol 1982;128:1484-6.
35. Witte MB, Barbul A. Wound healing: general principles of wound healing. Surg Clin N Am 1997;77:509-28.
36. Minchenko A, Salceda S, Bauer T, Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 1994;40:35-9.
37. Patel B, Khaliq A, Jarvis-Evans J, et al. Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells. Biochem Mol Biol Int 1994;34:639-44.
38. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor type alpha: a more potent angiogenic mediator than epidermal growth factor. Science 1986; 232:1250-3.
39. Grotendorst GR, Pencev D, Martin GR, et al. Molecular mediators of tissue repair. In: Hunt TK, Heppenstall RB, Pines E, et al, editors. Soft and hard tissue repair: biological and clinical aspects. New York: Praeger; 1984. p. 20.
40. Gailit J, Clark RA. Wound repair in the context of extracellular matrix [review]. Curr Opin Cell Biol 1994; 6:717-25.
41. Simpson DM, Ross R. The neutrophilic leukocyte in wound repair: a study with antineutrophil serum. J Clin Invest 1972;51:2009-23.
42. Erlich HP. The role of connective tissue matrix in wound healing. In: Hunt TK, editor. Growth factors and other aspects of wound healing: biological and clinical implications. Alan R Liss, Inc.; 1988. p. 243-58.
43. Circolo A, Welgus HG, Pierce GF, et al. Differential regulation of the expression of proteinases/antiproteinases in fibroblasts: effects of interleukin-1 and platelet-derived growth factor. J Biol Chem 1991;266:12283-8.
44. Fauci AS. Resistance to HIV-1 infection: its in the genes. Nat Med 1996;2:966-7.
45. Scannell G, Waxman K, Kaml GJ, et al. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J Surg Res 1993;54(4):281-5.
46. Gharaee-Kermani M. Role of cytokines and cytokine therapy in wound healing and fibrotic disease. Curr Pharm Des 2001;7(11):1083-103.
47. Ross R. Platelet-derived growth factor. Ann Rev Med 1987;38:71-9.
48. Seppä H, Grotendorst GR, Seppä S, et al. Platelet-derived growth factor in chemotactic for fibroblasts. J Cell Biol 1982;92:584-8.
49. Roberts AB, Anzano MA, Wakefield LM, et al. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 1985; 82:119-23.
50. Postlethwaite AE, Keski-Oja L, Moses HL, et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor-β. J Exp Med 1987;165:251-6.
51. Westermark B, Blomquist W. Stimulation of fibroblast migration by epidermal growth factor. Cell Biol Int Rep 1980;4:649-54.
52. Hynes RO. Integrins: versatility, modulation and signaling in cell adhesion. Cell 1992;69:11.
53. Singer II, Scott S, Kawka DW, et al. Cell surface distribution of fibronectin and vibronectin receptors depends on substrate composition and extracellular matrix accumulation. J Cell Biol 1988;106:2171-82.
54. Ahlen K, Rubin K. Platelet-derived growth factor-BB stimulates synthesis of the integrin alpha 2-subunit in human diploid fibroblasts, Exp Cell Res 1994; 215:347.
55. Gailit J, Bueller H, Clark R. Platelet-derived growth factor and inflammatory cytokines have differential effects on the expression of integrins alphalβ1 and alpha 5β1 by human dermal fibroblasts. J Cell Physiol 1996; 169:281-9.
56. Grzesiak HH, Piershbacher MD. Shifts in concentrations of magnesium and calcium in early porcine and rat wound fluids activate the cell migratory response. J Clin Invest 1995;95:227-33.
57. Reed MJ, Puolakkainen P, Lane TF, et al. Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem 1993;41:1467-77.
58. Parks WC. Matrix metalloproteinases in repair. Wound Repair Reg 1999;7:423-33.
59. Parsons SL, Watson SA, Brown PD, et al. Matrix metalloproteinases. Br J Surg 1997;84:160-6.
60. Assoian RK, Sporn MB. Type beta transforming growth factor in human platelets: release during degranulation and action on vascular smooth muscle cells. J Cell Biol 1986;102:1217-23.
61. Werb Z, Tremble P, Damsky CH. Regulation of extracellular matrix degradation by cell-extracellular matrix interactions. Cell Differ Dev 1990;32:299-306.
62. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-7.
63. Gospodarowicz D, Neufeld G, Schweigerer L. Fibroblast growth factor: structural and biologic properties. J Cell Physiol 1987;5(Suppl 15):15-26.
64. Gospodarowicz D, Abraham J, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived follicular stellate cells. Proc Natl Acad Sci USA 1989;86:7311-5.
65. Shing Y, Folkmann J, Sullivan R, et al. Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984;223:1296-9.
66. Nanney LB, Magid M, Stoscheck CM, et al. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol 1984;83:385-93.
67. Niall M, Ryan GB, O'Brien BM. The effect of epidermal growth factor on wound healing in mice. J Surg Res 1982;33:164-9.
68. Wemer S, Peters KG, Longaker MT, et al. Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 1992;89:6896-900.
69. Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000;14:2123-33.
70. Cavani A, Zambruno G, Marconi A, et al. Distinctive integrin expression in the newly formed epidermis during wound healing in humans. J Invest Dermatol 1993; 101:600-4.
71. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988;107:2757-67.
72. Odland G, Ross R. Human growth repair: epidermal regeneration. J Cell Biol 1968;39:135-51.
73. Bullard KM, Lund L, Mudgett JS, et al. Impaired wound contraction in stromelysin-1 deficient mice. Ann Surg 1999;230:260-5.
74. Nimmi ME. Collagen: its structure and function in normal and pathological connective tissues. Semin Arthritis Rheum 1974;4:95-150.
75. Ignotz RA, Massaugue J. Transforming growth factorbeta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986;261:4337-45.
76. Caterson B, Lowther DA. Changes in the metabolism of the proteoglycans from sheep articular cartilage in response to mechanical stress. Biochem Biophys Acta 1978;540:412-22.
77. Fahey III TJ, Sadaty A, Jones II WG, et al. Diabetes impairs the late inflammatory response to wound healing. J Surg Res 1991;50:308-13.
78. Ketchum LD, Smith J, Robinson DW, et al. Treatment of hypertrophic scars, colloids and scar contractor by triamcinolone acetonide. Plast Reconstr Surg 1966; 38:209-18.
79. Reed MJ, Puolakkainen P, Lane TF, et al. Differential expression of SPARC and thrombospondin I in wound repair: immunolocalization and in situ hybridization. J Histochem Cytochem 1993;41:1467-77.
80. Hering TM, Marchant RE, Anderson JM. Type V collagen during granulation tissue development. Exp Mol Pathol 1983;39:219-29.
81. Veis A, Averey J. Modes of intermolecular crosslinking in mature insoluble collagen. J Biol Chem 1965; 240:3899-908.
82. Hassel JR, Kimura JH, Hascall VC. Proteoglycan core protein families. Ann Rev Biochem 1986;55:539-67.
83. Gabbianni G, Ryan GB, Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971;27:549-50.
84. Clark RA, Nielsen LD, Welch MP, McPherson JM. Collagen matrices attenuate the collagen synthetic response of cultured fibroblasts to TGF-β. J Cell Sci 1995; 108:1251-61.
85. Granstein RD, Murphy GF, Margolis RJ, et al. Gamma interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest 1987;79:1254-8.
86. Buck M, Houglum K, Chojkier M. Tumor necrosis factor-alpha inhibits collagen alpha a (I) gene expression and wound healing in a murine model of cachexia. Am J Pathol 1996;149:195-204.
87. Brew K, Kinakarpandian J, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000;1477:267-83.
88. Haroon ZA, Raleigh JA, Greenberg CS, et al. Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann Surg 2000;231:137-47.